C
Charles Mondo
Researcher at Mulago Hospital
Publications - 68
Citations - 22254
Charles Mondo is an academic researcher from Mulago Hospital. The author has contributed to research in topics: Heart failure & Population. The author has an hindex of 30, co-authored 60 publications receiving 16336 citations. Previous affiliations of Charles Mondo include Makerere University.
Papers
More filters
Journal ArticleDOI
Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): Rationale and design.
Mark Loeb,Hisham Dokainish,Hisham Dokainish,Antonio L. Dans,Lia M. Palileo-Villanueva,Ambuj Roy,Kamilu M. Karaye,Jun Zhu,Yan Liang,Fastone Goma,Albertino Damasceno,Khalid F. AlHabib,Gerald Yonga,Charles Mondo,Wael Almahmeed,Arif Al Mulla,Salim Yusuf,Salim Yusuf +17 more
TL;DR: This is the largest randomized trial to test if influenza vaccine compared to control reduces adverse vascular events in high risk individuals and aims to assess whether variables such as age, sex, seasonality modify the benefits of vaccination.
Journal ArticleDOI
Kidney disease in Uganda: a community based study
Robert Kalyesubula,Joaniter I. Nankabirwa,Isaac Ssinabulya,Trishul Siddharthan,James Kayima,Jane Nakibuuka,Robert A. Salata,Charles Mondo,Moses R. Kamya,Donald E. Hricik +9 more
TL;DR: A high prevalence of kidney disease is found in central Uganda and traditional risk factors such as HIV-infection, diabetes mellitus, smoking and alcohol intake were not found to be significantly associated with CKD.
Journal ArticleDOI
Gender differences in clinical characteristics and outcome of acute heart failure in sub-Saharan Africa: results of the THESUS-HF study
Okechukwu S Ogah,Okechukwu S Ogah,Beth A. Davison,Karen Sliwa,Karen Sliwa,Bongani M. Mayosi,Albertino Damasceno,Mahmoud U Sani,Charles Mondo,Anastase Dzudie,Dike B. Ojji,Charles Kouam Kouam,Ahmed Suliman,Neshaad Schrueder,Gerald Yonga,Sergine Abdou Ba,Fikru Maru,Bekele Alemayehu,Christopher L. Edwards,Gad Cotter +19 more
TL;DR: Although the outcome of patients admitted for AHF in sub-Saharan regions is similar in men and women, some gender differences are apparent suggesting that in men more emphasis should be put on modifiable life risk factors, while in women prevention of rheumatic heart diseases and improved nutrition should be addressed vigorously.
Journal ArticleDOI
Prognostic Significance of ECG Abnormalities for Mortality Risk in Acute Heart Failure: Insight From the Sub-Saharan Africa Survey of Heart Failure (THESUS-HF)
Anastase Dzudie,Olga Milo,Christopher R. W. Edwards,Gad Cotter,Beth A. Davison,Albertino Damasceno,Bongani M. Mayosi,Charles Mondo,Okechukwu S Ogah,Dike B. Ojji,Mahmoud U Sani,Karen Sliwa,Karen Sliwa +12 more
TL;DR: ECG abnormalities are almost universal among Africans with acute HF, which may add to the immediate diagnosis of patients presenting with dyspnea, and although some ECG findings have prognostic value for risk of adverse outcomes, most are nonspecific and add little to the risk stratification of these patients.
Journal ArticleDOI
Rationale and design of the Investigation of the Management of Pericarditis (IMPI) trial: a 2 × 2 factorial randomized double-blind multicenter trial of adjunctive prednisolone and Mycobacterium w immunotherapy in tuberculous pericarditis.
Bongani M. Mayosi,Mpiko Ntsekhe,Jackie Bosch,Janice Pogue,Freedom Gumedze,Motasim Badri,Hyejung Jung,Shaheen Pandie,Marek Smieja,Lehana Thabane,Veronica Francis,Kandithal M. Thomas,Baby Thomas,Abolade A. Awotedu,Nombulelo P. Magula,Datshana P Naidoo,Albertino Damasceno,Alfred Chitsa Banda,Arthur Mutyaba,Basil G. Brown,Patrick Ntuli,Phindile Mntla,Lucas M Ntyintyane,Rohan Ramjee,Pravin Manga,Bruce Kirenga,Charles Mondo,James B.W. Russell,Jacob M. Tsitsi,Ferande Peters,Mohammed R. Essop,Ayub Felix Barasa,Muhammad S Mijinyawa,Mahmoud U Sani,Taiwo Olunuga,Okechukwu S Ogah,Adewole A Adebiyi,Akinyemi Aje,VO Ansa,Dike B. Ojji,Solomon Danbauchi,James Hakim,Jonathan Matenga,Salim Yusuf +43 more
TL;DR: The IMPI trial is the largest trial yet conducted comparing adjunctive immunotherapy in pericarditis and its results will define the role of adj unctive corticosteroids and M. w Immunotherapy in patients with TB pericardiocentesis.